Clinical Trials Directory

Trials / Completed

CompletedNCT00981786

24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol

Quality of 24-hour Intraocular Pressure Control Obtained With the Brinzolamide/Timolol Fixed Combination Compared With the Brimonidine/Timolol Fixed Combination When Added to Travoprost Monotherapy in Subjects With Open-angle Glaucoma

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
51 (actual)
Sponsor
Aristotle University Of Thessaloniki · Academic / Other
Sex
All
Age
29 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The proposed crossover study will compare for the first time the quality of 24-hour intraocular pressure control with the combination of travoprost and brinzolamide/timolol compared with travoprost and brimonidine/timolol in glaucoma patients insufficiently controlled with travoprost. This comparison may determine the real efficacy of the two fixed combinations when added to the prostaglandin. The design of the proposed study should facilitate a better understanding of the role of these medications in glaucoma management.

Conditions

Interventions

TypeNameDescription
DRUGBrimonidine/timolol fixed combination drops added to travoprosttwice daily administration
DRUGBrinzolamide/timolol fixed combination drops added to travoprosttwice daily dosing

Timeline

Start date
2009-08-01
Primary completion
2010-09-01
Completion
2010-12-01
First posted
2009-09-22
Last updated
2020-12-17

Source: ClinicalTrials.gov record NCT00981786. Inclusion in this directory is not an endorsement.

24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol (NCT00981786) · Clinical Trials Directory